翔宇医疗
(688626)
| 流通市值：51.18亿 | | | 总市值：51.18亿 |
| 流通股本：1.60亿 | | | 总股本：1.60亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 732,040,421.44 | 674,347,252.31 | 758,930,002.21 | 663,783,494.21 |
| 应收票据及应收账款 | 56,825,531.77 | 61,062,283.31 | 56,916,501.32 | 54,885,177.69 |
| 其中：应收票据 | - | 764,676.02 | 192,090.91 | 976,000 |
| 应收账款 | 56,825,531.77 | 60,297,607.29 | 56,724,410.41 | 53,909,177.69 |
| 应收款项融资 | 270,705 | 300,000 | 300,000 | 300,000 |
| 预付款项 | 42,549,812.91 | 44,418,453.5 | 33,888,651.68 | 32,290,965.58 |
| 其他应收款合计 | 12,057,868.38 | 11,589,741.31 | 9,294,251.63 | 7,417,506.52 |
| 存货 | 240,905,036.2 | 244,747,938.77 | 243,465,927.15 | 241,366,072.32 |
| 合同资产 | 2,827,250.62 | 2,785,690.22 | 4,931,662.27 | 2,804,401.44 |
| 其他流动资产 | 44,432,571.58 | 40,308,595.39 | 27,275,194.35 | 29,306,880.98 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,131,909,197.9 | 1,079,559,954.81 | 1,302,979,412.83 | 1,194,347,026.51 |
| 非流动资产: | | | | |
| 长期应收款 | 38,829,919.83 | 42,983,809.45 | 44,756,153.84 | 45,622,848.01 |
| 长期股权投资 | 13,203,275.39 | 13,156,431.61 | 12,935,334.49 | 13,113,239.99 |
| 其他权益工具投资 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 |
| 固定资产 | 509,307,243.89 | 513,839,137.04 | 403,559,132.35 | 396,899,151.13 |
| 在建工程 | 589,071,162.31 | 495,901,899.15 | 471,196,354.07 | 428,830,970.69 |
| 使用权资产 | 5,379,884.45 | 5,807,915.73 | 8,028,105.23 | 8,630,421.65 |
| 无形资产 | 215,704,269.23 | 208,557,731.77 | 207,417,649.81 | 207,699,347.11 |
| 长期待摊费用 | 7,158,126.15 | 5,837,657.89 | 5,938,387.27 | 5,716,318.65 |
| 递延所得税资产 | 6,539,455.36 | 7,699,026.73 | 10,817,709.16 | 11,219,237.01 |
| 其他非流动资产 | 275,627,821.79 | 273,734,582.12 | 289,259,815.76 | 270,041,950.78 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,670,821,158.4 | 1,577,518,191.49 | 1,463,908,641.98 | 1,397,773,485.02 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,802,730,356.3 | 2,657,078,146.3 | 2,766,888,054.81 | 2,592,120,511.53 |
| 流动负债: | | | | |
| 短期借款 | 329,990,000 | 216,990,000 | 287,015,000 | 27,015,000 |
| 应付票据及应付账款 | 82,239,116.82 | 95,475,452.87 | 86,458,125.51 | 109,889,145.66 |
| 其中：应付票据 | 1,690,435.35 | 4,541,601.27 | 2,694,509.4 | 6,692,414.13 |
| 应付账款 | 80,548,681.47 | 90,933,851.6 | 83,763,616.11 | 103,196,731.53 |
| 合同负债 | 112,029,890.55 | 104,032,190.08 | 91,145,311.19 | 107,555,064.92 |
| 应付职工薪酬 | 25,549,527.09 | 24,354,637.08 | 22,587,175.8 | 23,344,477.5 |
| 应交税费 | 10,692,194.12 | 7,891,212.07 | 5,630,852.99 | 12,849,035.74 |
| 其他应付款合计 | 48,031,983.55 | 52,870,731.63 | 53,631,857.81 | 74,693,534.21 |
| 其他流动负债 | 15,435,993.87 | 14,567,016.32 | 13,345,418.82 | 16,794,132.73 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 623,968,706 | 516,181,240.05 | 559,813,742.12 | 372,140,390.76 |
| 非流动负债: | | | | |
| 租赁负债 | 5,418,076.47 | 6,325,787.55 | 8,543,099.79 | 8,443,005.74 |
| 递延收益 | 131,442,924.65 | 104,581,523.54 | 104,372,722.43 | 104,109,085.32 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 136,861,001.12 | 110,907,311.09 | 112,915,822.22 | 112,552,091.06 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 760,829,707.12 | 627,088,551.14 | 672,729,564.34 | 484,692,481.82 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 160,000,000 | 160,000,000 | 160,000,000 | 160,000,000 |
| 资本公积 | 1,299,419,079.37 | 1,299,395,219.95 | 1,297,002,183.81 | 1,294,137,332.62 |
| 减:库存股 | 160,308,381.43 | 155,624,061.27 | 153,791,981.95 | 98,931,608.86 |
| 盈余公积 | 80,000,000 | 80,000,000 | 80,000,000 | 80,000,000 |
| 未分配利润 | 646,514,480.03 | 629,736,410 | 694,769,020.11 | 655,695,191.59 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,025,625,177.97 | 2,013,507,568.68 | 2,077,979,221.97 | 2,090,900,915.35 |
| 少数股东权益 | 16,275,471.21 | 16,482,026.48 | 16,179,268.5 | 16,527,114.36 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,041,900,649.18 | 2,029,989,595.16 | 2,094,158,490.47 | 2,107,428,029.71 |
| 负债和股东权益合计 | 2,802,730,356.3 | 2,657,078,146.3 | 2,766,888,054.81 | 2,592,120,511.53 |
| 公告日期 | 2024-10-30 | 2024-08-30 | 2024-04-18 | 2024-04-18 |
| 审计意见(境内) | | | | 标准无保留意见 |